For more information on clinical trials or to participate in one of our open trials, please contact our Research Coordinator via email or via phone at 856-218-5790.
The National Cancer Institute (NCI)-sponsored e3 Breast Cancer Study (Evaluating Everolimus with Endocrine therapy), looks to enroll 3,500 women and men being treated for hormone receptor-positive bre…
The Oncotype DX® test is a commercially available test that is already being used in practice to assess the risk that breast cancer will come back after surgery. The test looks at multiple genes relat…
The importance of effective local therapy (surgery, radiation therapy) as a means of optimizing survival in women with non-metastatic breast cancer is well established. However, approximately 5% of wo…
Ductal carcinoma in situ (DCIS) is the most common type of non-invasive breast cancer, and it gives rise to the majority of invasive breast cancers. Thus it is an important entity to understand and to…
Louise M. Baca RN MSN - Cancer Center Administrator
Eric Gonzalez, RN, OCN - Nurse Navigator
Appointment scheduling and treatment navigation.
Abigale Hassel, MSW, LCSW, OSW-C - Social Worker
Patient support and information.
Well-Being Yoga - Afternoon - 08/19/2014
Yoga, which increases flexibility, range of motion and strength, may bring additional benefits both during and after cancer treatments. When tension is released, energy flows more easily in the body, allowing participants to experience a sense of well-being.
Mindfulness and Meditation - 08/19/2014
This class will not meet during the summer. It will resume in the fall beginning September 15th.